首页> 外文会议>Trends in Radiopharmaceuticals(ISTR-2005) >INHIBITORS OF ADRENAL P-450c11 HYDROXYLASE CHARACTERIZEDBY TWO RADIOLIGANDS AND STEROID HORMONE SECRETION
【24h】

INHIBITORS OF ADRENAL P-450c11 HYDROXYLASE CHARACTERIZEDBY TWO RADIOLIGANDS AND STEROID HORMONE SECRETION

机译:肾上腺P-450c11羟化酶特性的抑制作用两种放射线虫和甾体激素分泌

获取原文

摘要

Metyrapone, a known inhibitor of 11β-hydroxylation in the adrenal cortex, usedclinically for the treatment of hypercortisolism, and etomidate, a known anesthetic drug witha potent side effect (inhibition of cortisol biosynthesis) binds with high affinity to rat adrenalmembranes. Derivatives of etomidate and of metyrapone were used as displacers of specificradioligand binding using 4-131I-iodophenyl-metomidate (131I-IMTO) and 3H-metyrapol asradioligands, respectively. Analogues of etomidate displaced both radioligands with similarpotencies, whereas derivatives of metyrapone and structurally related compounds appeared asbetter displacers of 3H-metyrapol binding. Selected correlates were also tested as inhibitors ofcortisol production measured in cell cultures by a known assay. Inhibition of cortisolproduction correlated well with the inhibitory potencies obtained by 131I-IMTO binding.
机译:富罗像酮,在肾上腺皮质中的11β-羟基化的已知抑制剂,使用 临床上用于治疗高凝集性,以及依赖于素质的毒性药物 有效的副作用(抑制皮质醇生物合成)与大鼠肾上腺的高亲和力结合 膜。依托咪酯和甲状腺素的衍生物用作特定的脱落剂 使用4-131i-碘苯基 - Metomide(131i-IMTO)和3H-甲坡的放射性配体结合 分别放射性配体。戊胺的类似物质使得两种放射性配体具有相似的 效力,而Metyrapone和结构相关化合物的衍生物出现为 更好的3h-metyrapol结合的流离失所者。选择的相关性也被测试为抑制剂 通过已知的测定,在细胞培养物中测量皮质醇生产。抑制皮质醇 通过131i-IMTO结合获得的抑制性能良好地相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号